Overall survival of elderly patients with breast cancer is not related to breast-cancer specific survival: A single institution experience in Japan
Autor: | Fumiaki Yotsumoto, Haruko Takuwa, Wakako Tsuji |
---|---|
Rok vydání: | 2018 |
Předmět: |
Male
Oncology Cancer Research Population ageing medicine.medical_specialty Breast Neoplasms Disease-Free Survival Breast Neoplasms Male Metastasis 03 medical and health sciences 0302 clinical medicine Breast cancer Drug Therapy Japan Internal medicine medicine Overall survival Humans 030212 general & internal medicine Single institution Aged Retrospective Studies Aged 80 and over business.industry Standard treatment Age Factors Cancer Retrospective cohort study General Medicine Prognosis medicine.disease Survival Rate 030220 oncology & carcinogenesis Female Neoplasm Recurrence Local business |
Zdroj: | Breast Disease. 37:177-183 |
ISSN: | 1558-1551 0888-6008 |
DOI: | 10.3233/bd-170280 |
Popis: | BACKGROUND As the aging population grows, the number of elderly breast cancer patients has rapidly increased especially in Japan; a suitable treatment for elderly patients, considering chronic comorbidities and treatment tolerance, is urgently needed. METHODS In this retrospective study, 286 elderly breast cancer patients were investigated. Tumor characteristics and survival outcome were compared between 70-79-year-old and ≥ 80-year-old groups. Disease-free survival, overall survival, and breast cancer-specific survival were compared, and the effect of variables was analyzed statistically. For resectable cases, prognoses were compared based on treatment (standard therapy or undertreated). RESULTS Tumor characteristics were similar between groups, but the Ki-67 labeling index tended to be higher in older patients. Elderly patients with resectable cancer tended to be undertreated. During the median 59-month follow-up period, overall survival was significantly worse in the ≥80-year-old than in the 70-79-year-old group (p < 0.001), but disease-free and breast cancer-specific survivals were equivalent. Recurrence or death event hazard rates tended to be lower in patients receiving standard treatment. CONCLUSIONS Standard multidisciplinary treatment for breast cancer prevents recurrence and metastasis and tends to extend breast cancer-specific survival even in elderly patients. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |